Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NE › Beatrice › NPI 1184642894
Hospital

Beatrice Community Hospital & Health Center INC

Beatrice Community Hospital & Health Center INC was paid $10.42M by Medicaid between Jan 2018 and Dec 2024, across 166 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.

33Billing provider infoBEATRICE COMMUNITY HOSPITAL & HEALTH CENTER INC
BEATRICE, NE 68310
33aNPI1184642894assigned 07/18/2006
33bProvider typeCritical Access Hospital
28Total paid$10.42M
24GClaims203,355
24DCodes billed166
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Nebraska

Rank by total paid#1 of 53
Median peer was paid$593K
This provider vs. median18×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201824,960$1.27M
201927,150$1.24M
202027,297$1.31M
202147,126$2.43M
202251,370$2.63M
202320,716$1.17M
2024incomplete4,736$350K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 17% 11,772 10,310 $1.75M
74177 Computed tomography, abdomen and pelvis; with contrast material 5.3% 406 371 $550K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.9% 3,560 2,810 $511K
80053 Comprehensive metabolic panel 4.4% 12,037 10,251 $461K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4.0% 14,779 12,121 $417K
70450 Computed tomography, head or brain; without contrast material 3.4% 697 643 $351K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.8% 3,042 2,655 $296K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.3% 5,586 1,724 $244K
71046 Radiologic examination, chest; 2 views 2.2% 2,352 2,143 $227K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.1% 2,047 1,874 $216K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2.0% 3,973 3,809 $212K
J3490 Unclassified drugs 1.8% 6,795 3,354 $189K
154 more codes
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.8% 1,863 $188K
84443 Thyroid stimulating hormone (TSH) 1.8% 3,848 $183K
36415 Collection of venous blood by venipuncture 1.7% 18,356 $180K
99285 Emergency room visit (most serious) 1.5% 718 $157K
87631 1.5% 2,008 $152K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.3% 5,466 $137K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.3% 2,638 $137K
96375 Therapeutic injection; each additional sequential IV push 1.3% 2,003 $136K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.3% 2,502 $133K
71045 Radiologic examination, chest; single view 1.2% 1,594 $126K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.0% 2,221 $105K
84484 <1% 2,040 $103K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 159 $102K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,591 $97K
80048 Basic metabolic panel (calcium, ionized) <1% 3,484 $95K
87660 <1% 2,095 $92K
87510 <1% 2,267 $92K
87480 <1% 2,267 $92K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,976 $92K
96361 Intravenous infusion, hydration; each additional hour <1% 2,952 $90K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 68 $90K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,602 $86K
G0378 Hospital observation service, per hour <1% 125 $82K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,773 $82K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 746 $77K
80061 Lipid panel <1% 2,996 $77K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 428 $73K
J7030 Infusion, normal saline solution , 1000 cc <1% 3,038 $67K
81003 <1% 5,722 $65K
83036 Hemoglobin; glycosylated (A1C) <1% 3,023 $64K
84145 <1% 1,882 $63K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 719 $63K
59025 Fetal non-stress test <1% 473 $62K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,681 $59K
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 6,129 $56K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,923 $52K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 755 $51K
73630 <1% 431 $51K
83690 <1% 1,359 $50K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,300 $50K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,595 $48K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 706 $46K
77067 Screening mammography, bilateral, including computer-aided detection <1% 445 $42K
81001 <1% 2,744 $39K
97161 <1% 896 $38K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 677 $37K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 671 $35K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 470 $33K
83605 <1% 1,533 $33K
87428 <1% 778 $32K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,005 $32K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 999 $32K
81025 <1% 1,769 $31K
J2704 Injection, propofol, 10 mg <1% 712 $31K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 205 $29K
0099U <1% 118 $29K
83880 <1% 677 $28K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 637 $28K
85027 <1% 1,523 $28K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 99 $25K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 625 $23K
83735 <1% 887 $20K
76830 Ultrasound, transvaginal <1% 78 $20K
74018 <1% 151 $20K
73610 <1% 157 $18K
84702 <1% 333 $18K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 651 $17K
99213 Doctor's office visit, returning patient (routine) <1% 204 $16K
84439 <1% 959 $15K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 112 $14K
85610 <1% 1,074 $14K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 142 $14K
80306 <1% 389 $14K
86703 <1% 330 $13K
87040 <1% 1,076 $13K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 37 $13K
73030 <1% 126 $12K
86140 <1% 760 $11K
80055 <1% 62 $11K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 111 $10K
73562 <1% 95 $10K
83550 <1% 371 $10K
96376 <1% 157 $10K
83655 <1% 289 $10K
83540 <1% 394 $9K
72125 Computed tomography, cervical spine; without contrast material <1% 12 $8K
J2270 Injection, morphine sulfate, up to 10 mg <1% 164 $8K
85018 <1% 590 $8K
77063 Screening digital breast tomosynthesis, bilateral <1% 247 $8K
82728 <1% 358 $8K
85379 <1% 244 $7K
85652 <1% 399 $6K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 154 $6K
J1170 Injection, hydromorphone, up to 4 mg <1% 145 $6K
84703 <1% 530 $5K
73110 <1% 59 $5K
82570 <1% 241 $5K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 110 $5K
82607 <1% 259 $4K
J7050 Infusion, normal saline solution, 250 cc <1% 569 $4K
82043 <1% 130 $4K
87420 <1% 136 $3K
80320 <1% 74 $3K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 204 $3K
73502 <1% 30 $3K
80050 General health panel <1% 25 $3K
86850 <1% 57 $2K
87808 <1% 159 $2K
73130 <1% 32 $2K
87070 <1% 75 $2K
J0690 Injection, cefazolin sodium, 500 mg <1% 16 $2K
82962 <1% 559 $2K
87486 <1% 114 $2K
87581 <1% 113 $2K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 24 $2K
86901 <1% 59 $2K
85730 <1% 46 $2K
J2550 Injection, promethazine hcl, up to 50 mg <1% 26 $2K
87653 <1% 24 $2K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 95 $2K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 17 $1K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 38 $1K
86900 <1% 58 $1K
87205 <1% 92 $1K
73564 <1% 12 $1K
87075 <1% 70 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 26 $1K
74019 <1% 13 $1K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 15 $1K
82803 <1% 14 $956.36
82950 <1% 43 $925.11
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 18 $861.92
A9270 Non-covered item or service <1% 163 $777.71
36416 <1% 254 $769.26
97165 <1% 14 $690.63
84481 <1% 17 $545.60
84153 <1% 13 $502.40
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 240 $500.45
84156 <1% 16 $492.42
87340 <1% 13 $308.76
86803 <1% 17 $287.25
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 24 $275.00
86141 <1% 31 $238.49
86592 <1% 15 $232.26
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 33 $217.18
87430 <1% 12 $141.00
84100 <1% 15 $116.06
82565 <1% 13 $104.06
82044 <1% 24 $99.81
99214 Doctor's office visit, returning patient (more involved) <1% 13 $55.92
J7060 5% dextrose/water (500 ml = 1 unit) <1% 19 $5.22
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml <1% 18 $0.22
3044F <1% 786 $0.03
3051F 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHARALDSON, RICK (CEO)